Original Research
Published on 30 Jan 2025
Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancer
in Radiation Oncology
- 2,944 views
- 1 citation